Gregory Scott Duncan - Dec 21, 2021 Form 4 Insider Report for Virios Therapeutics, Inc. (VIRI)

Role: CHIEF EXECUTIVE OFFICER, Director
Signature: /s/ Greg Duncan
Stock symbol: VIRI
Transactions as of: Dec 21, 2021
Transactions value $: $27,615
Form type: 4
Date filed: 12/22/2021, 12:23 PM
Previous filing: Jun 22, 2021
Next filing: Feb 23, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VIRI	Common Stock	Purchase	$27.6K	+5K	+25.05%	$5.52^*	25K	Dec 21, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.395 to $5.708, inclusive. The reporting person undertakes to provide Virios Therapeutics, Inc. ("Virios"), any security holder of Virios or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

Content

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.395 to $5.708, inclusive. The reporting person undertakes to provide Virios Therapeutics, Inc. ("Virios"), any security holder of Virios or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.